Scitaris is a tremendous partner supporting multiple of our portfolio companies on critical strategic questions. With their unique combination of scientific rigor, drug development expertise, custom-made databases, and a seamlessly integrating, flexible working style, we can recommend Scitaris to anyone looking for scientifically driven, high-quality strategic advice.

Scitaris’ intellect and passion for the work is remarkable. Moreover, it is not every day you get to work with talented people that you really enjoy being in their company and interacting on a daily basis - - - this is certainly true with all of the team.

The Scitaris team were tremendous partners in our efforts to evaluate new business opportunities to add to our product portfolio. Their insight across all of the critical segments – scientific data, clinical path, regulatory, commercial, competitive landscape – made the process efficient and productive for our Management team. I would recommend this group for anyone needing to make strategic additions to their company offerings.

I have had the pleasure of working with the Scitaris team on multiple projects for multiple companies. In every case, my colleagues and I have been extremely impressed with the collaboration process and the product. From corporate level strategy to detailed scientific assessments, their team provided clear, decision quality advice and durable content across a broad area of research and development interests. Scitaris makes a point of clearly understanding the needs of the business and then consistently apply their knowledge, technology, experience, and work ethic in support of each collaboration.

Over the years, we have fostered a long-standing relationship with the Scitaris team as they hit the sweet spot of deep scientific understanding, industry experience and strategic thinking in our highly complex and fast-paced world of Immuno-Oncology. They have supported us on various questions ranging from corporate and business development strategy to asset-level indication strategy. I would not hesitate to recommend them to anyone with pressing questions in the realm of R&D strategy

Over the last years, I have had the pleasure to work with Scitaris on some key strategic projects for our firm and was, without exception, extremely impressed by the exceptional quality of the firms work. They never relied on ‘off the shelf solutions’ for challenges but unceasingly came up with innovative and tailor-made approaches, in all cases adding real value to the company. This, coupled with his exceptionally high standards of quality, deep industry knowledge and strong managerial skills, positions Scitaris as one of the top advisors in the industry.

We were fortunate to be introduced to the Scitaris team to work on the articulation of the vision and strategy for our oncology platform. This was an intense assignment in the context of ongoing partnering discussions. The Scitaris team brought tremendous value by understanding the big picture, while at the same time working hard on the accuracy of the details and supporting data. The immediate outcome was a very successful business development discussion where our partner was excited about our company and projects. The longer-term outcome is the creation of a simple and compelling framework to organize and prioritize our clinical development programs. Beyond this, the Scitaris team was a pleasure to work with and we look forward to have them as an enduring advisor to our team.

…my sincere thank-you for all your work on this. I am repeatedly awe-struck by the speed, quality, and depth of Scitaris’ work…

The unique combination of strong analytical skills, strategic thinking, systematic use of methodology, and excellent people skills makes Jonathan exceptionally qualified to support organization with complex business problems. A result-driven and constructive individual that delivers high quality work with focus on implementation and business execution.

I worked with the Scitaris team on an extensive portfolio review exercise. My colleagues and I found the team to be very diligent, meticulous, knowledgeable and systematic, delivering work of the highest quality in a complex field. They were engaged, proactive and took an efficient approach which yielded a very useful report that we continue to use to this day as a decision-making tool. I look forward to working with them at another opportunity and would highly recommend Scitaris.

Graham has worked with myself and the team at Merck KGaA’s healthcare business to challenge therapeutic asset investment decisions and to guide the company’s inorganic investment strategy. Graham is incredibly diligent in his analysis and able to recognize patterns and anomalies that very few could identify, let alone appropriately value. As a consequence, his work has directly supported go/no go investment decisions and been of tremendous value

I could write a novel about how great you and your team are, but will keep it short and sweet: Thank you from the bottom of our hearts. We value the Scitaris team tremendously and really appreciate everything you have done in going above and beyond for us